These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23223323)

  • 1. [Reactogenicity and immunogenicity of intradermal flu vaccine among the medical students of the University of Rome Tor Vergata].
    Morciano L; Zaratti L; Carlino C; Visconti G; Magrini A; Franco E
    Ig Sanita Pubbl; 2012; 68(5):749-58. PubMed ID: 23223323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.
    Coleman BL; McGeer AJ; Halperin SA; Langley JM; Shamout Y; Taddio A; Shah V; McNeil SA
    Vaccine; 2012 Sep; 30(44):6287-93. PubMed ID: 22902784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influenza vaccination: coverage and risk perception among students of the health professions at Florence University, Italy].
    Bonaccorsi G; Lorini C; Porchia BR; Niccolai G; Martino G; Giannarelli L; Santomauro F
    Ann Ig; 2013; 25(3):181-9. PubMed ID: 23598801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults.
    Ansaldi F; de Florentiis D; Durando P; Icardi G
    Expert Rev Vaccines; 2012 Jan; 11(1):17-25. PubMed ID: 22149703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.
    Coleman BL; McNeil SA; Langley JM; Halperin SA; McGeer AJ
    Vaccine; 2015 Nov; 33(48):6635-40. PubMed ID: 26529074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R; Icardi G; De Decker M; Ambrozaitis A; Kazek MP; Weber F; Van Damme P
    Vaccine; 2009 Dec; 27(52):7304-12. PubMed ID: 19849996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
    Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
    Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
    Leroux-Roels I; Vets E; Freese R; Seiberling M; Weber F; Salamand C; Leroux-Roels G
    Vaccine; 2008 Dec; 26(51):6614-9. PubMed ID: 18930093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-critical videos on YouTube and their impact on medical students' attitudes about seasonal influenza immunization: a pre and post study.
    Robichaud P; Hawken S; Beard L; Morra D; Tomlinson G; Wilson K; Keelan J
    Vaccine; 2012 May; 30(25):3763-70. PubMed ID: 22484293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical faculty and school of health student knowledge of and behavior regarding swine flu and vaccine, in Kahramanmaras, Turkey.
    Ozer A; Kirecci E; Ekerbicer HC; Celik M
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):161-7. PubMed ID: 21323179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS; Peiris JS; Chan KH; Wong WH; Lau YL
    Pediatrics; 2007 Jun; 119(6):1076-82. PubMed ID: 17545373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators.
    Foy JE; Hendriksz T; Malouf P; Tobin A
    J Am Osteopath Assoc; 2013 Feb; 113(2):134-43. PubMed ID: 23412675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are medical residents a "core group" for future improvement of influenza vaccination coverage in health-care workers? A study among medical residents at the University Hospital of Palermo (Sicily).
    Amodio E; Tramuto F; Maringhini G; Asciutto R; Firenze A; Vitale F; Costantino C; Calamusa G
    Vaccine; 2011 Oct; 29(45):8113-7. PubMed ID: 21856362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical students' attitude toward influenza vaccination: Results of a survey in the University of Bari (Italy).
    Gallone MS; Gallone MF; Cappelli MG; Fortunato F; Martinelli D; Quarto M; Prato R; Tafuri S
    Hum Vaccin Immunother; 2017 Aug; 13(8):1937-1941. PubMed ID: 28463582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF
    Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults.
    Lopez P; Caicedo Y; Sierra A; Tilman S; Banzhoff A; Clemens R
    J Infect Dis; 2011 Jun; 203(12):1719-28. PubMed ID: 21606530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.